← Back to headlines
Bristol Myers Raises 2026 Forecast on Strong Drug Performance
Bristol Myers has raised its 2026 forecast, attributing the improved outlook to the strong performance of its drug Eliquis and other newer medicines.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
